| General Information of Drug Metabolite (DM) (ID: DM001171) |
| DM Name |
Desmethylpantoprazole
|
|
|
|
|
|
|
|
| Full List of Drug-Metabolizing Enzyme (DME) Related to This DM |
| DME(s) Producing This DM through Metabolism |
| DME Name |
DME ID |
Reactant |
Reaction |
Related Drug |
REF |
|
Mephenytoin 4-hydroxylase (CYP2C19)
|
DME0021
|
| Oxidation - Demethylation |
Pantoprazole sodium
|
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Full List of Drug(s) That Produce This DM By Metabolism |
| Pantoprazole sodium |
DR1236
|
Approved |
Gastro-oesophageal reflux disease |
|
|
| References |
| 1 |
Proton pump inhibitors: from CYP2C19 pharmacogenetics to precision medicine. Expert Opin Drug Metab Toxicol. 2018 Apr;14(4):447-460.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
